Theresa Kehoe

628 total citations
9 papers, 425 citations indexed

About

Theresa Kehoe is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, Theresa Kehoe has authored 9 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Orthopedics and Sports Medicine and 3 papers in Molecular Biology. Recurrent topics in Theresa Kehoe's work include Bone health and osteoporosis research (4 papers), Bone health and treatments (3 papers) and Bone Metabolism and Diseases (3 papers). Theresa Kehoe is often cited by papers focused on Bone health and osteoporosis research (4 papers), Bone health and treatments (3 papers) and Bone Metabolism and Diseases (3 papers). Theresa Kehoe collaborates with scholars based in United States, Netherlands and United Kingdom. Theresa Kehoe's co-authors include G. K. BENSON, Jia Guo, Princy Kumar, Adrian S. Dobs, Todd T. Brown, Joseph Timpone, Mary D. Ruppe, Stephen Clement, George P. Chrousos and Norio Azumi and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Clinical Pharmacology & Therapeutics.

In The Last Decade

Theresa Kehoe

8 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Theresa Kehoe United States	7	250	225	90	77	69	9	425
Vijaya Mysorekar India	10	54 0.2×	46 0.2×	14 0.2×	70 0.9×	24 0.3×	44	321
Rolf M. Anner Switzerland	7	12 0.0×	49 0.2×	42 0.5×	71 0.9×	21 0.3×	11	324
Athena T. Samaras United States	10	106 0.4×	131 0.6×	3 0.0×	39 0.5×	26 0.4×	20	334
Geoffrey P. Doherty Canada	10	49 0.2×	63 0.3×	10 0.1×	118 1.5×	18 0.3×	15	610
T.J. Nevill Canada	10	14 0.1×	130 0.6×	13 0.1×	22 0.3×	17 0.2×	12	431
Emese Tóth Belgium	8	180 0.7×	61 0.3×	5 0.1×	56 0.7×	65 0.9×	15	313
Ilana Shraga-Slutzky Israel	9	40 0.2×	89 0.4×	3 0.0×	22 0.3×	36 0.5×	13	329
A. Wang United States	8	447 1.8×	371 1.6×	4 0.0×	249 3.2×	61 0.9×	15	577
Julia Thomson Australia	3	224 0.9×	70 0.3×	4 0.0×	80 1.0×	36 0.5×	4	326
Lisa M. Smith United States	11	53 0.2×	7 0.0×	15 0.2×	52 0.7×	43 0.6×	19	602

Countries citing papers authored by Theresa Kehoe

Since Specialization

Citations

This map shows the geographic impact of Theresa Kehoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresa Kehoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresa Kehoe more than expected).

Fields of papers citing papers by Theresa Kehoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresa Kehoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresa Kehoe. The network helps show where Theresa Kehoe may publish in the future.

Co-authorship network of co-authors of Theresa Kehoe

This figure shows the co-authorship network connecting the top 25 collaborators of Theresa Kehoe. A scholar is included among the top collaborators of Theresa Kehoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresa Kehoe. Theresa Kehoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Smith, Kimberly, Theresa Kehoe, Mark Levenson, et al.. (2025). US Food and Drug Administration's Advancing Real‐World Evidence Program: Initial Experience. Clinical Pharmacology & Therapeutics. 118(3). 545–547. 1 indexed citations

2.

Kehoe, Theresa, E. Blind, & Heidi Janssen. (2018). Regulatory aspects of the development of drugs for metabolic bone diseases – FDA and EMA perspective. British Journal of Clinical Pharmacology. 85(6). 1208–1212. 7 indexed citations

3.

Li, Fang, Myong‐Jin Kim, Theresa Kehoe, et al.. (2018). Regulatory Perspectives in Pharmacometric Models of Osteoporosis. The Journal of Clinical Pharmacology. 58(5). 572–585. 11 indexed citations

4.

Guo, Jia, et al.. (2012). Bisphosphonates for Osteoporosis — Where Do We Go from Here?. New England Journal of Medicine. 366(22). 2048–2051. 249 indexed citations

5.

Erridge, Simon, et al.. (2007). Reducing Waiting Times: A Whole Department Approach. Clinical Oncology. 19(3). S9–S9. 1 indexed citations

6.

Kehoe, Theresa. (2006). Bone quality: A perspective from the food and drug administration. Current Osteoporosis Reports. 4(2). 76–79. 6 indexed citations

7.

Brown, Todd T., Mary D. Ruppe, Princy Kumar, et al.. (2004). Reduced Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients and Its Association with Increased Central Adiposity and Postload Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1200–1206. 93 indexed citations

8.

Koch, Christian A., Norio Azumi, Mary Furlong, et al.. (1999). Carcinoid Syndrome Caused by an Atypical Carcinoid of the Uterine Cervix. The Journal of Clinical Endocrinology & Metabolism. 84(11). 4209–4213. 33 indexed citations

9.

Kirshbom, Paul M., Aftab R. Kherani, Mark W. Onaitis, et al.. (1999). Foregut carcinoids: A clinical and biochemical analysis. Surgery. 126(6). 1105–1110. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact